233 related articles for article (PubMed ID: 23082988)
1. Tbx3 represses PTEN and is over-expressed in head and neck squamous cell carcinoma.
Burgucu D; Guney K; Sahinturk D; Ozbudak IH; Ozel D; Ozbilim G; Yavuzer U
BMC Cancer; 2012 Oct; 12():481. PubMed ID: 23082988
[TBL] [Abstract][Full Text] [Related]
2. MiR-206 inhibits Head and neck squamous cell carcinoma cell progression by targeting HDAC6 via PTEN/AKT/mTOR pathway.
Liu F; Zhao X; Qian Y; Zhang J; Zhang Y; Yin R
Biomed Pharmacother; 2017 Dec; 96():229-237. PubMed ID: 28987947
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional profiling identifies upregulated genes following induction of epithelial-mesenchymal transition in squamous carcinoma cells.
Humtsoe JO; Koya E; Pham E; Aramoto T; Zuo J; Ishikawa T; Kramer RH
Exp Cell Res; 2012 Feb; 318(4):379-90. PubMed ID: 22154512
[TBL] [Abstract][Full Text] [Related]
4. Blockade of adenosine A2A receptor enhances CD8
Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
[TBL] [Abstract][Full Text] [Related]
5. Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling.
Hall B; Nakashima H; Sun ZJ; Sato Y; Bian Y; Husain SR; Puri RK; Kulkarni AB
J Transl Med; 2013 Feb; 11():45. PubMed ID: 23421960
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Novel Proto-oncogenic Network in Head and Neck Squamous Cell Carcinoma.
Georgy SR; Cangkrama M; Srivastava S; Partridge D; Auden A; Dworkin S; McLean CA; Jane SM; Darido C
J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26063791
[TBL] [Abstract][Full Text] [Related]
7. FOXM1 induces a global methylation signature that mimics the cancer epigenome in head and neck squamous cell carcinoma.
Teh MT; Gemenetzidis E; Patel D; Tariq R; Nadir A; Bahta AW; Waseem A; Hutchison IL
PLoS One; 2012; 7(3):e34329. PubMed ID: 22461910
[TBL] [Abstract][Full Text] [Related]
8. Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.
Sepiashvili L; Hui A; Ignatchenko V; Shi W; Su S; Xu W; Huang SH; O'Sullivan B; Waldron J; Irish JC; Perez-Ordonez B; Liu FF; Kislinger T
Mol Cell Proteomics; 2012 Nov; 11(11):1404-15. PubMed ID: 22918226
[TBL] [Abstract][Full Text] [Related]
9. Association of SIRT1 and tumor suppressor gene TAp63 expression in head and neck squamous cell carcinoma.
Kikuchi K; Noguchi A; Kasajima R; Miyagi Y; Hoshino D; Koshikawa N; Kubota A; Yokose T; Takano Y
Tumour Biol; 2015 Sep; 36(10):7865-72. PubMed ID: 25946975
[TBL] [Abstract][Full Text] [Related]
10. Anterior gradient protein 2 expression in high grade head and neck squamous cell carcinoma correlated with cancer stem cell and epithelial mesenchymal transition.
Ma SR; Wang WM; Huang CF; Zhang WF; Sun ZJ
Oncotarget; 2015 Apr; 6(11):8807-21. PubMed ID: 25871396
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of pseudogene PTENP1 promotes malignant behaviours and is associated with the poor survival of patients with HNSCC.
Liu J; Xing Y; Xu L; Chen W; Cao W; Zhang C
Sci Rep; 2017 Jan; 7():41179. PubMed ID: 28112249
[TBL] [Abstract][Full Text] [Related]
12. The effect of LKB1 on the PI3K/Akt pathway activation in association with PTEN and PIK3CA in HNC.
Ekizoglu S; Dogan S; Ulker D; Seven D; Gozen ED; Karaman E; Buyru N
Clin Otolaryngol; 2015 Dec; 40(6):622-8. PubMed ID: 25850957
[TBL] [Abstract][Full Text] [Related]
13. miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells.
Vahabi M; Pulito C; Sacconi A; Donzelli S; D'Andrea M; Manciocco V; Pellini R; Paci P; Sanguineti G; Strigari L; Spriano G; Muti P; Pandolfi PP; Strano S; Safarian S; Ganci F; Blandino G
J Exp Clin Cancer Res; 2019 Mar; 38(1):141. PubMed ID: 30925916
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA alterations in head and neck squamous cell carcinoma.
Chang SS; Jiang WW; Smith I; Poeta LM; Begum S; Glazer C; Shan S; Westra W; Sidransky D; Califano JA
Int J Cancer; 2008 Dec; 123(12):2791-7. PubMed ID: 18798260
[TBL] [Abstract][Full Text] [Related]
15. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.
Rampias T; Pectasides E; Prasad M; Sasaki C; Gouveris P; Dimou A; Kountourakis P; Perisanidis C; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
Ann Oncol; 2013 Aug; 24(8):2124-31. PubMed ID: 23406730
[TBL] [Abstract][Full Text] [Related]
16. Identification of TRPC6 as a possible candidate target gene within an amplicon at 11q21-q22.2 for migratory capacity in head and neck squamous cell carcinomas.
Bernaldo de Quirós S; Merlo A; Secades P; Zambrano I; de Santa María IS; Ugidos N; Jantus-Lewintre E; Sirera R; Suarez C; Chiara MD
BMC Cancer; 2013 Mar; 13():116. PubMed ID: 23497198
[TBL] [Abstract][Full Text] [Related]
17. L-DOPA decarboxylase mRNA expression is associated with tumor stage and size in head and neck squamous cell carcinoma: a retrospective cohort study.
Geomela PA; Kontos CK; Yiotakis I; Fragoulis EG; Scorilas A
BMC Cancer; 2012 Oct; 12():484. PubMed ID: 23083099
[TBL] [Abstract][Full Text] [Related]
18. The anti-proliferative function of the TGF-β1 signaling pathway involves the repression of the oncogenic TBX2 by its homologue TBX3.
Li J; Ballim D; Rodriguez M; Cui R; Goding CR; Teng H; Prince S
J Biol Chem; 2014 Dec; 289(51):35633-43. PubMed ID: 25371204
[TBL] [Abstract][Full Text] [Related]
19. PTEN expression is involved in the invasive properties of HNSCC: a key protein to consider in locoregional recurrence.
Mriouah J; Boura C; Gargouri M; Plénat F; Faivre B
Int J Oncol; 2014 Mar; 44(3):709-16. PubMed ID: 24366426
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics-based discovery of PYGM and TNNC2 as potential biomarkers of head and neck squamous cell carcinoma.
Jin Y; Yang Y
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31324732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]